Tag: Prescription Drugs
Some Lupus Erythematosus Cases Tied to Drug Exposure
Cases found for both cutaneous and systemic lupus, but some previous reports due to protopathic bias
Sodium Phenylbutyrate-Taurursodiol Promising for ALS
Slower functional decline seen with active drug versus placebo through 24 weeks
Empagliflozin Superior to Placebo for Heart Failure
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
VA/DoD Issue Guideline for Diagnosis, Management of HTN
Measurement of BP; target treatment goals; nonpharmacologic, pharmacologic therapy discussed
ADA Updates Guideline for Pharmacotherapy of T2DM
Metformin preferred as initial agent; early combined therapy can extend time to treatment failure
About Half of Waivered Clinicians Prescribe Buprenorphine for OUD
Percentages much higher for actively prescribing U.S. clinicians with 275 and 100 versus 30 patients
Electronic Alert May Cut Excessive SABA Prescribing in Asthma
Repeat SABA prescribing for patients with asthma decreased in the 12 months following the alert
Antihypertensive Agents Not Tied to Higher Risk for Depression
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
RAAS Inhibitors May Benefit HTN Patients With COVID-19
Risk for death, death/critical outcomes lower with use of RAAS inhibitors for hypertension
Clinical Impact of Remdesivir in Moderate COVID-19 Unclear
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
